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The cytoplasmic membrane of bacterial cells, forming an essential barrier from the
surroundings, is a critical component of cellular physiology ensuring proper survival and
maintenance of major cellular functions. The integrity of the membrane is an important feature
that plays an essential role in the transport of solutes and nutrients through active and passive
pathways, functions of membrane-associated proteins, electron transport and ATP synthesis,
maintaining turgor pressure and combating environmental stresses, and thus is a crucial factor of
a majority of cellular adaptations. The various biophysical properties affecting the integrity of this
membrane are mainly determined by the composition and proportion of the fatty acyl residues of
membrane phospholipid backbone which are subject to dynamic changes in response to the
external environment to regulate the ideal fluidity/viscosity of the membrane. This enables the
bacteria to adapt to changing environments. Additionally, membrane fatty acid composition has a
major influence on bacterial pathogenesis and virulence, susceptibility to antimicrobials and
broader aspects of bacterial physiology.

Gram-positive bacterial membranes are made mostly of varying proportions of straightchain and branched-chain fatty acids distributed on the phosphatidyl glycerol molecules along with
unsaturated fatty acids in some case. Membrane fatty acid biosynthesis that determines this lipid
composition has gained attention over recent years as a novel and efficient target for therapeutic
agents. A key to study the dynamics of the membrane and its relation to the bacterial physiology
is to design successful tools to induce or study alterations, native or novel, to the lipid composition
and analyze the resulting consequences on major cellular attributes. This thesis describes the
studies of the membranes of two major gram- positive bacterial pathogens, Listeria monocytogenes
and Staphylococcus aureus, both posing a threat to human health due to either unsuccessful
containment or rapid antibiotic resistance acquirement. The first chapter describes the modulations
in the membrane composition of Listeria monocytogenes, a psychrophilic bacterium, through
chemical supplementation which results in novel fatty acids by non-native enzymatic reactions
and the consequences on the bacterial physiology. The second chapter outlines the versatility of
Staphylococcus aureus membrane fatty acid composition in differencing growth environments, in
vitro or in vivo. The following research will contribute a better understanding of fundamental
membrane biophysical parameters in these bacterial pathogens that has been the target for novel
drugs for a decade now, along with providing knowledge to support the intensive search for newer
and more effective infection control strategies.
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CHAPTER I
SHORT BRANCHED- CHAIN C6 CARBOXYLIC ACIDS RESULT IN INCREASED
GROWTH, NOVEL ‘UNNATURAL’ FATTY ACIDS AND INCREASED
MEMBRANE FLUIDITY IN A LISTERIA MONOCYTOGENES
BRANCHED- CHAIN FATTY ACID-DEFICIENT
MUTANT

ABSTRACT
Listeria monocytogenes is a psychrotolerant food borne pathogen, responsible for the high
fatality disease listeriosis, and expensive food product recalls. Branched-chain fatty acids
(BCFAs) of the membrane play a critical role in providing appropriate membrane fluidity and
optimum membrane biophysics. The fatty acid composition of a BCFA-deficient mutant is
characterized by high amounts of straight-chain fatty acids and even-numbered iso fatty acids, in
contrast to the parent strain where odd-numbered anteiso fatty acids predominate. The presence
of 2-methylbutyrate (C5) stimulated growth of the mutant at 37ºC and restored growth at 10ºC
along with the content of odd-numbered anteiso fatty acids. The C6 branched-chain carboxylic
acids 2-ethylbutyrate and 2-methylpentanoate also stimulated growth to a similar extent as 2methylbutyrate. However, 3-methylpentanoate was ineffective in rescuing growth. 2ethylbutyrate and 2-methylpentanoate led to novel major fatty acids in the lipid profile of the
membrane that were identified as 12-ethyltetradecanoic acid and 12-methylpentadecanoic acid
1

respectively. Membrane anisotropy studies indicated that growth of strain MOR401 in the
presence of these precursors increased its membrane fluidity to levels of the wild type. Cells
supplemented with 2-methylpentanoate or 2-ethylbutyrate at 10ºC shortened the chain length of
novel fatty acids, thus showing homeoviscous adaptation. These experiments use the mutant as a
tool to modulate the membrane fatty acid compositions through synthetic precursor
supplementation, and show how existing enzymes in L. monocytogenes adapt to exhibit nonnative activity yielding unique ‘unnatural’ fatty acid molecules, which nevertheless possess the
correct biophysical properties for proper membrane function in the BCFA-deficient mutant.

2

1. Introduction
Listeria monocytogenes is a Gram-positive, foodborne, intracellular pathogen that is the
causative agent of listeriosis. The organism is also responsible for periodic expensive food product
recalls when food is found to be contaminated with L. monocytogenes. Early this year, a total of
35 people were infected from a multistate Listeria outbreak from prepackaged Granny Smith and
Gala apples. This was closely followed by a major statewide outbreak from Blue Bell creamery
products followed by immediate recalls and reports that the contamination dated back several years
(http://www.cdc.gov/listeria/outbreaks). The ability of L. monocytogenes to grow at refrigeration
temperatures is an important factor in its role as a foodborne pathogen [1].
The fatty acid composition of the L. monocytogenes cytoplasmic membrane is unusual in
that it is composed almost entirely of branched-chain fatty acids (BCFAs) [2, 3, 4]. Typically, the
major fatty acids of the organism are anteiso C15:0, anteiso C17:0 and iso C15:0. This fatty acid
composition enables L. monocytogenes to adapt to growth at low temperatures, mainly by
increasing the content of anteiso C15:0 by a combination of fatty acid chain shortening and
branched-chain switching from iso to anteiso [2, 3, 4, 5]. This is a homeoviscous adaptation to
maintain appropriate membrane fluidity [6].
BCFAs are biosynthesized from the branched-chain amino acids isoleucine (anteiso fatty
acids), leucine (odd-numbered iso fatty acids) and valine (even-numbered iso fatty acids) via
branched-chain amino acid transaminase and branched- chain α-keto acid dehydrogenase (Bkd)
[7]. Mutants in the bkd gene cluster are cold-sensitive, deficient in BCFAs, and have lower
membrane fluidity that the parent strain, and all these defects can be corrected with the shortbranched- chain carboxylic acids (BCCAs) that act as precursors for BCFAs via a pathway that
bypasses the branched- chain amino acids and Bkd [2, 5, 8, 9].
3

Studies with the cold-sensitive mutants, cld-1 and cld-2 revealed a switch in the fatty acid
composition to one where the major fatty acids are straight-chain fatty acids (SCFAs) and iso-even
BCFAs [2, 5, 8, 9], a fatty acid profile incompatible with good growth at low temperature due to
high membrane viscosity. In the absence of branched-chain keto acid dehydrogenase activity it is
proposed that the SCFAs originate from butyryl CoA, and isobutyryl CoA. Isobutyryl CoA, the
precursor of even-numbered iso BCFAs, may be produced via valine dehydrogenase or
isomerization of butyryl CoA [2]. However, the biophysical properties of the membrane have
broader impacts in listerial physiology and pathogenicity than just cold adaptation. Giotis et al.
[10] have shown that the BCFA-deficient cld mutants tolerate acidic and alkaline pH less well than
the parent strain, a tolerance that can be restored by medium supplementation with 2-methyl
butyrate (2-MB). Sun and O’ Riordan [11] showed that BCFA-deficient mutants grew and
survived less well in macrophages, exhibited decreased production of the key virulence factor
listeriolysin O, and were highly attenuated in a murine model of infection. In an extension of these
studies, BCFAs played a critical role in protection against antimicrobial peptides and
peptidoglycan hydrolases [12]. In all these cases 2-MB restored the anteiso C15:0 and anteiso
C17:0 fatty acid content and the defects in the mutants to a large extent.
In 1971 Kaneda [13] showed that various C6 BCCAs led to the production of novel fatty
acids derived from these precursors in Bacillus subtilis. 2-ethylbutyrate (2-EB) and 2methylpentanoate (2-MP) were the most effective precursors. These two precursors in high (100
mM) concentrations also led to the production of novel “unnatural” fatty acids when added to the
cultures of wild type L. monocytogenes [14]. Also, Willecke and Pardee [15] studied a set of
chemical analogues of natural BCFA-yielding precursors and found that a B. subtilis bkd mutant
used them in the same pattern as noted by Kaneda (1971) [13]. However, neither of these studies
4

examined the effects of the C6 BCCA precursors on growth at low temperatures. It was of interest
to see whether these precursors would stimulate the growth of BCFA-deficient L. monocytogenes
mutant MOR401 at various temperatures, and see what impact they had on the fatty acid
composition of the mutants and their membrane biophysical properties. 2-MP and 2-EB
supplementation led to major amounts of novel fatty acids, increased membrane fluidity, and
stimulated the growth of the BCFA-deficient mutant at 37°C and 10ºC.
2. Materials and methods
2.1. Bacterial strains and growth conditions
L. monocytogenes strains used in this study were parent strain 10403S and cold-sensitive
mutant MOR401 (kindly provided by Yvonne Sun and Mary X. D. O'Riordan) harboring a Tn917
transposon insertion in the lpd gene of the bkd gene cluster (lipoamide dehydrogenase, E3) created
by transduction of the mutation from strain cld-2 [2, 5] into strain 10403S [11]. The strains were
grown in Brain-Heart Infusion (BHI) broth (Difco Laboratories, Detroit, MI). Starter cultures of
mutant strain MOR401 were grown in medium supplemented with erythromycin (1 ug ml-1).
For growth and fatty acid composition studies 50 ml of BHI medium, not supplemented with
any antibiotic, in a 300 ml Erlenmeyer flask were inoculated with 2% (vol/vol) of overnight starter
culture. The cells were grown at 37°C and 10°C with continuous shaking at 200 rpm in the
presence of 1 mM concentrations of 2-MB and the C6 BCCAs 2-EB, 2-MP and 3-methyl
pentanoate (3-MP) along with a wide range of other short BCCAs with varying chain lengths
shown in Table 1. Straight chain precursor, butyrate, was used as a negative control. These BCCAs
and butyrate were neutralized with 10 M NaOH to a final pH of 7.0 and added to BHI as filter
sterilized solutions. The growth kinetics of the strains were monitored by measuring OD600 using
5

a Beckman DU-65 spectrophotometer. Cultures were appropriately diluted after the OD600 reached
0.5. Growth experiments were carried out on three separate occasions, and results of representative
experiments are shown.
2.2. Membrane fatty acid analysis
Cells grown in BHI with or without the BCFA precursors were harvested in mid-exponential
phase (OD600 0.4-0.6) by centrifugation at 3000 x g at 4°C for 15 minutes, and the pellet was
washed 3 times with cold sterile distilled water. The fatty acids in the bacterial cells (30 to 40 mg
[wet weight]) were saponified, methylated, and extracted. The resulting methyl ester mixtures were
separated using an Agilent 5890 dual-tower gas chromatograph and identified using the MIDI
microbial identification system (Sherlock 4.5 microbial identification system) at Microbial ID, Inc.
(Newark, DE) [14, 5]. Minor fatty acids (<1% of the total) are not reported in the tables. Novel
BCFAs were further characterized by electron ionization mass spectroscopy [16].
2.3. Determination of the membrane fluidity
Membrane fluidity was determined through anisotropy measurements using the fluorophore
1,6-diphenyl-1,3,5-hexatriene (DPH) which specifically fluoresces in the hydrophobic domain of
fatty acyl chains in the lipid bilayer of the membrane [17]. Exponential phase (OD600 0.4-0.6) cells
grown with or without precursors were pelleted by centrifugation at 3000 x g at 4°C for 15 minutes
and washed twice with 0.85% (wt/vol) NaCl solution. The cells were resuspended in 0.85%
(wt/vol) NaCl containing 2 µM DPH (Sigma, MO) to an OD600 of 0.3 and incubated at 37°C for 1
hr. The resulting fluorescence polarization values of DPH were measured in a PTI fluorescence
spectrophotometer using FelixGX software. Excitation of the ﬂuorescent probe was accomplished
with vertically polarized monochromatic light at 360 nm for DPH, with emission intensity
6

quantiﬁed at 426 nm, using a detector oriented either parallel to or perpendicular to the direction
of the polarized excitation source. Lower fluidity leads to decreased movement of the probe in the
membrane. This subsequently results in lesser distortion of the emitted signal and higher
anisotropy values recorded by the fluorimeter.
2.4. Light microscopy
The bacterial cells were grown in BHI broth or BHI broth supplemented with BCCA
precursors at 37°C and harvested at mid log phase. The pellets were washed with PBS and Gramstained. The cells were then observed via light microscopy using differential interference contrast
with the 100X objective.
3. Results
3.1. The C6 BCCAs stimulate growth of the BCFA-deficient mutant
It is well established that C5 BCCA 2-MB enhances the growth of BCFA-deficient strains
of L. monocytogenes [2, 5], and this is confirmed in Fig. 1a and 1b. The growth of the parent and
MOR401 in unsupplemented BHI medium at 37°C is shown in Fig. 1a. The lag phase of strain
MOR401 was significantly longer than the parent strain, the growth rate was slower and the final
cell density achieved was considerably lower. As expected, 2-MB markedly stimulated the growth
of the mutant at 37°C such that the growth rate and the final cell density achieved were similar to
the parent strain. Interestingly the lag phase of strain MOR401 was not reduced significantly by
the presence of 2-MB. C6 BCCA 2-MP had an effect on growth very similar to 2-MB, as did 2EB except for a slightly longer period to exit lag phase with this precursor. The extended lag phase
of the mutant may be related to its impairment in cell division that we noted-see Fig. 4. The
precursor 3-MP had a negligible stimulating effect on growth compared to 2-MB, 2-MP or 2-EB.
7

Butyrate, a C4 straight-chain carboxylic acid, which can generate SCFAs [14], served as a negative
control that had no stimulatory effect on growth.
At 10°C (Fig. 1b) the results were more striking. The mutant barely grew at this temperature,
and growth was further diminished by inclusion of the C4 straight-chain carboxylic acid butyrate
in the medium. Strikingly, 2-MP and 2-EB were equally effective if not more effective than 2-MB
in stimulating growth. It is proposed that 2-MP and 2-EB act as precursors for novel unnatural
fatty acids that are incorporated into the membrane [13,14,15], yet which appear to have properties
that result in ideal membrane fluidity and appropriate membrane biophysical properties to allow
the mutant to grow at 10°C.
3.2.Growth in the presence of C6 BCCAs results in novel membrane fatty acids
Given the growth stimulatory effects of the C6 BCCAs it seemed likely that they were
altering the membrane fatty acid composition of strain MOR401. Accordingly, the fatty acid
compositions of cells grown in the absence and presence of 1 mM concentrations of the BCCAs
at 37°C were determined. The gas liquid chromatograph traces are shown in Fig. 1 (Supplemental)
and the fatty acid compositions are shown in Table 2. Strain MOR401 has a significantly different
fatty acid composition from its parent strain 10403S (Table 2). Ninety eight per cent of the fatty
acids were BCFAs in the parent strain, with the major fatty acids being anteiso C15:0 and C17:0
and iso C15:0. In contrast BCFAs only made up 33% of the total in strain MOR401 and the major
fatty acids were C16:0, C14:0 and iso C16:0 (Table 2 and Fig 1a supplemental). However, when
strain MOR401 was grown in the presence of 2-MB two major peaks appeared in the gas
chromatograph trace with retention times of 2.44 and 3.08 minutes (Fig. 1b supplemental) that
were identified as anteiso C15:0 (52.3%) and anteiso C17:0 (40.8%).The results are in perfect
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accord with previous studies on strain cld-2 [2, 5, and 12]. Growth in the presence of 2-MP led to
two novel major peaks in the chromatograph with retention times of 2.61 and 3.24 min (Fig. 1c
supplemental), respectively, constituting 64.5 and 12.3% of the total fatty acids. In fatty acid
biosynthesis two carbon atoms are added at a time to a precursor CoA molecule until the fatty acid
chain reaches the required length for incorporation into the membrane [18]. In this case the
precursor molecule is postulated to be 2-MP-CoA and the two fatty acids are postulated to be 12methylpentadecanoic acid (C16) and 14-methylheptadecanoic acid (C18). Similarly, the presence
of 1 mM 2-EB in the medium resulted in two major peaks of retention times 2.75 and 3.38 min,
respectively constituting 50.4 and 31.6% of the total fatty acids (Fig. 1d supplemental). These fatty
acids are postulated to be 12-ethyltetradecanoic acid (C16) and 14-ethylhexadecanoic acid (C18)
respectively. Very similar results were found when the experiments were performed with strain
cld-2 (unpublished observations). Mass spectral analysis (Fig. 2a and b) revealed a spectrum
corresponding to an ethyl branch on the 12th carbon of a 14 carbon chain (peak one) and an ethyl
branch on the 14th carbon of a 16 carbon chain (peak two) of these two major peaks in the gas
chromatogram. Clearly 2-MP and 2-EB led to the production of novel fatty acids that under normal
circumstances would not normally be found in a bacterial membrane. However, their physical
structures apparently endow the membrane with biophysical properties that result in stimulation
of the growth of the BCFA-deficient mutant at both temperatures.
In order to achieve membrane homeoviscosity at low temperatures L. monocytogenes
increases the proportion of fatty acid anteiso C15:0 in its lipids [2, 5, 8], by fatty acid chain
shortening and branching switching. It was therefore of interest to observe whether any changes
occurred in the proportions of the unnatural even-numbered fatty acids in response to growth at
low temperatures. When grown in the presence of 2-MP at 10°C, 10-methyltridecanoic acid
9

increased from 1.04 to 14.4%, 14-methylheptadecanoic acid decreased from 12.3 to 0.5% in strain
MOR401 and 12-methylpentadecanoic acid increased to 66% from 64% (Table 3) compared to
cells grown at 37ºC (Table 2). Similarly, when grown at 10°C in the presence of 2-EB, 12ethyltetradecanoic acid increased to 65.9% from 50%, and 14-ethylhexadecanoic acid decreased
to 14.2% from 31.6% (Table 3) compared to cells grown at 37ºC (Table 2). Thus, even with the
novel BCFAs the cells can execute successful homeoviscous adaptation at low temperature due to
fatty acid shortening.
3.3.Incorporation of unnatural even-numbered BCFAs results in increased membrane fluidity
It was expected that given the incorporation of large amounts of the novel fatty acids and the
enhancement of the growth of the mutant the membrane fluidity of the cells grown in the presence
of 2-MP and 2-EB would be enhanced compared to growth in unsupplemented BHI medium.
When strain MOR401 was grown in unsupplemented BHI medium at 37ºC it exhibited a
polarization value of 0.24, which was much higher than that observed in the parent strain (0.17)
under the same conditions, and indicates a less fluid membrane (Fig. 3). This directly correlates
with the deficiency of odd-numbered anteiso fatty acids along with a high proportion of SCFAs
and even iso fatty acids in the mutant. When the medium was supplemented with the different
BCFA precursors, there was a considerable decrease in the anisotropy values confirming an
increase in the fluidity of the membrane (Fig. 3). Inclusion of 2-MB restored the fluidity close to
the wild-type, as did 2-EB and 2-MP (Fig. 3).
3.4. BCCA supplementation helps restore normal cell division of the BCFA-deficient mutant
Light microscopic analysis of the bacterial cells showed that when grown in unsupplemented
BHI broth, strain MOR401 appeared to be unusually long (almost 3µm) with irregular division
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sites (identified by arrows in Fig. 4), in contrast to the wild type cells which are short rods. It seems
that the BCFA deficiency and decreased membrane fluidity interfere with proper division of the
mutant. Supplementation with 2-MB, which reinstates BCFA content and fluidity of the
membrane, restored normal division of the cells. 2-EB also showed similar effects on cell division
which indicates the novel BCFAs generated from synthetic substrates can also provide the
appropriate biophysical properties to the membrane for normal cell division.
3.5 A 2-position branch in the exogenous BCCA precursors effectively rescued the growth of
the mutant
A range of BCCAs, with variations in chain lengths and branching patterns, were studied
for their ability to stimulate the growth of the strain MOR401 in order to study the fundamental
structural requirements for functioning as an efficient fatty acid precursor. The mutant was grown
in the presence of each of these precursors at 37ºC and the growth kinetics were determined (Fig.
5) Like butyrate none of the corresponding straight-chain substrates - pentanoate (C5), hexanoate
(C6) or heptanoate (C7) had any influence on growth of the mutant (data not shown). Among the
various BCCA precursors studied of varying chain lengths, the position of branching and nature
of branching, a methyl, dimethyl or ethyl branch at the 2 position were found to be effective in
stimulating the growth of the mutant at 37ºC (Fig. 5). Trimethyl acetate and 2,2-dimethylbutyric
acid were efficient in rescuing growth at 37ºC, but to a lesser extent than 2-MB. Trimethyl acetate
supplementation yielded two primary novel peaks of retention times 2.26 and 2.89 which are
postulated to be 12-dimethyltridecanoic acid and 14-dimethylpentadecanoic acid respectively,
each constituting about 20% of the total membrane fatty acid composition (Table 2). 2,2dimethylbutyrate supplementation also had a similar outcome with the membrane having a total
of 85% BCFA of which 12,12-dimethyltetradecanoic acid (retention time 2.57 min) and 14,14dimethylhexadecanoic acid( retention time 3.21 min) were postulated to be the novel fatty acids.
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However these precursors were unable to support the growth of the mutant at low temperatures.
The fluidity of the membrane was moderately increased by the dimethyl branched precursors (Fig.
3).
Although we observed that a branch at the second position was crucial for the precursors to
rescue the growth of the mutant, the length of the carbon chain plays a role too. Among the 2
carbon-branched BCCAs we tested, IB, 2-MB, 2-MP (chain lengths of 3, 4 and 5 respectively)
were highly efficient in stimulating the growth of the BCFA mutant. However, the efficacy
decreased drastically when 2-methylhexanoate was used as a substrate, which has a chain length
of 6 carbons. This decreased efficiency may be because of inefficient conversion to the
corresponding CoA derivative by the bypass pathway enzymes, or inefficient utilization of the
CoA precursors by FabH.
4. Discussion
a. Fatty acid biosynthesis in the BCFA-deficient mutant
Strain MOR401 contains a Tn917 insertion in the lpd gene of the bkd operon and thus has a
nonfunctional branched-chain keto acid dehydrogenase enzyme complex. This leads to a strikingly
different fatty acid composition than the parent strain, 10403S, in which even numbered SCFAs
make up about 65% of the total fatty acids and iso-even numbered fatty acids about 25% in the
mutant. The iso-even numbered fatty acids are biosynthesized from isobutyryl-CoA. Under normal
circumstances this fatty acid primer is produced from the branched-chain amino acid valine via
branched-chain amino acid transaminase followed by branched-chain keto acid dehydrogenase
activities (Fig. 6). This route is not operative in strain MOR401 [5]. Potential alternative routes to
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isobutyryl-CoA include from valine via valine dehydrogenase, and by isomerization of butyrylCoA [2].
FabH carries out the first condensation reaction in fatty acid biosynthesis [18]. Butyryl-CoA
is likely to be the precursor for the SCFAs found in high amounts in MOR401 because L.
monocytogenes FabH has very low activity with acetyl-CoA, the only other likely possible
precursor of even numbered SCFAs [19]. However, there does not appear to be any information
on how butyryl-CoA might be formed endogenously in L. monocytogenes. It is not known whether
butyrate is present in BHI medium to act as a source of butyryl-CoA. However, when strain cld-2
(from which MOR401 is derived) is grown in defined medium without butyrate the strain’s fatty
acid composition is also characterized by a high proportion of even numbered SCFAs [2]. This
would also argue against longer chain fatty acids being incorporated into the phospholipids of the
organism from the growth medium, such as happens in S. aureus [20]. A possible route to butyrylCoA is via the condensation of two molecules of acetyl-CoA to form acetoacetyl-CoA, a reaction
catalyzed by the enzyme thiolase followed by a series of enzymatic reactions studied extensively
in butyrate-producing bacteria such as species of Clostridium [21]. When a genome-wide search
for these enzymes or their homologs was carried out throughout the Listeria genus including L.
monocytogenes strains 10403S and EGDe, they all seem to be present (data not shown), although
not well characterized. Thus it seems feasible that in absence of pathways producing BCFAs in
the membrane, butyryl-CoA production and its corresponding elongation leads to SCFAs
dominating the membrane profile of the BCFA-deficient mutant.
When MOR401 (or cld-2) is supplied with 2-MB in the medium it causes a dramatic switch
in fatty acid composition such that anteiso C15:0 and C17:0 become almost 90% of the total fatty
acid composition (Table 2) [2, 5]. This clearly results in a membrane with much more ideal
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biophysical properties for the organism, enabling it to grow efficiently even at low temperatures.
Thus there appears to be a bypass to allow the organism to utilize an exogenous supply of short
BCCA precursors yielding acyl-CoA primers ready to enter FASII elongation pathway. 2-MBCoA
is the preferred L. monocytogenes FabH substrate with the highest activity among various
precursors tested [19]. Although the pathway to 2-MBCoA from an exogenous source has not been
ascertained yet, the bkd operon contains two genes upstream of the bkd cluster, buk and ptb,
encoding butyrate kinase (Buk) and phosphotransbutyrylase (Ptb) respectively [5], which could
function to produce 2-MBCoA after 2-MB crosses the L. monocytogenes cytoplasmic membrane
as depicted in Fig 6.
Supply of 2-MP and 2-EB in the growth medium also results in very high proportions of
fatty acids in the membrane derived from them, not observed under normal circumstances.
Clearly, a pathway must exist to produce 2-MPCoA and 2-EBCoA and these C6 primer
molecules are then used efficiently by FabH for elongation and incorporation. Buk and Ptb,
which we hypothesize form 2-MBCoA from 2-MB, are also likely to catalyze the formation of
the CoA derivatives from 2-MP and 2-EB suggesting a relatively wide substrate specificity of the
enzymes. It would be interesting to characterize the kinetic parameters of FabH with these
substrates, as well as those of the enzymes in the pathway leading to production of 2-MPCoA
and 2-EBCoA. Our unpublished observations show that the C6 BCCA substrates can be
efficiently utilized by Ptb.
b. Membrane fluidity and physiological properties of 2-MP- and 2-EB-grown
BCFA-deficient mutant
Both 2-MP and 2-EB stimulated growth of MOR401 at 37ºC and restored growth of the
strain at 10ºC. The main fatty acids generated from these precursors, 12-methylpentadecanoic
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acid and 12-ethyltetradecanoic acid respectively, although unnatural provide the membrane with
biophysical properties that restore its functional efficiency. Strain MOR401 is impaired in cell
division producing short chains of unusually long and irregularly dividing cells. Inclusion of 2MB, 2-MP, or 2-EB in the medium corrects this and restores the normal cellular arrangement of
the strain. This suggests that low membrane fluidity somehow interferes with the complex
process of cell division carried out by the divisome [22], and when the ideal fluidity is restored
through sufficient BCFA production in the membrane the cell regains its normal physiology and
can divide successfully. This proves that as long as the fatty acid molecule can provide the
correct biophysical properties it does not necessarily have to be a natural cellular product. A
suitable synthetic precursor can be very well utilized by the bacterial system to restore its ideal
membrane parameters. Mercier et al. [23] have demonstrated a crucial role for BCFAs and their
associated membrane fluidity in membrane scission in “L-form” B. subtilis cells.
The impact of the natural anteiso fatty acids having a methyl branch at the antepenultimate
position such as anteiso C15:0 on the fluidity of the cytoplasmic membranes is attributed to the
larger cross-sectional area they occupy than the corresponding SCFAs. This increases the area per
lipid, and disrupts close packing of the fatty acyl chains and chain order along with reducing
thickness of the lipid bilayer [15, 24]. A recent study on the effects of methyl branched fatty acids
on the structural properties of the lipid bilayer using a 1,2-dipalmitoyl-sn glycerol-3phosphocholine lipid bilayer, showed that the position of the methyl branch on the fatty acyl chain
directly influences the membrane fluidity, the fluidizing ability of a mid-chain branch being greater
than a terminal one [24]. The branching of 2-MP and 2-EB-derived fatty acids also no doubt
occupy a large cross-sectional area similar to the naturally occurring BCFAs, thereby also
imparting significant fluidity to the membrane.
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c. Psychrotolerance of L. monocytogenes
In order to survive in the cold, psychrophiles must have enzymes that perform effectively at
low temperatures.

Indeed, cold environments reduce enzyme reaction rates and increase

membrane viscosity. Cold-adapted organisms cope with these conditions by increasing enzyme
turnover or improved catalytic efficiency at low temperatures compared to homologous enzymes
in mesophiles. A commonly accepted hypothesis for cold adaptation is that psychrophilic enzymes
have an increased flexibility of their structure to compensate for the “freezing effect” at cold
temperatures [25]. Such changes are not without cost as this increased flexibility is likely
responsible for the lower protein stability generally associated with cold-adapted enzymes,
especially at higher temperatures.
L. monocytogenes is not psychrophilic, but rather psychrotolerant, which sets up a
paradoxical survival problem for this organism. It must be able to thrive at 37oC and thus cannot
afford thermally unstable enzymes, yet it maintains the ability to grow at refrigeration
temperatures, which presumably requires increased enzymatic flexibility. Previously, we revealed
that L. monocytogenes was uniquely equipped to handle just such a paradox, in that even during
exponential growth at 37oC, anteiso-C15:0 accounted for 48% of the total fatty acids [2]. Although
other Gram positive bacteria incorporate BCFAs into their membranes, their levels of anteisoC15:0 are consistently ~30%, comparable to the cold-sensitive L. monocytogenes mutants, cld-1
and cld-2 and MOR401 [2, 5]. Comparative analysis of the crystal structures of several bacterial
FabH enzymes suggests a molecular basis for their substrate specificity [26]. Steric interactions
between conserved physically close phenylalanines (distant in primary structure, e.g., between F305
and F208 in L. monocytogenes) cause a narrowing of the FabH active site in Gram-positive bacteria.
The perturbing residue (i.e. F208) is not well conserved in Gram-negative bacteria (e.g. V216 in E.
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coli), which then allows the active site phenylalanine residue to swing away from the active site
and open the substrate cavity [26]. Substrate specificity of FabH is the determining factor in the
biosynthesis of BCFAs by type II fatty acid synthases [27, 28]. Accordingly, FabH enzymes from
organisms that produce BCFAs exhibit broader substrate specificity than FabH homologues from
organisms which produce SCFAs [27]. It is this broader substrate utilization that permits the
phenomenon of homeoviscous adaptation to low temperatures by fatty acid branch switching and
chain length shortening which occurs in wild-type L. monocytogenes and BCFA-deficient mutants
in growth medium supplemented with 2-MB [2, 5, 8].
An increase in the proportion of the shorter fatty acids derived from 2-MP and 2-EB
accompanied by a decrease in the proportion of the longer ones was also observed in adaptation
to low temperature. Thus L.monocytogenes can also carry out homeovisocus adaptation with the
novel fatty acids derived from these unique precursors.
d. Structural requirements for a precursor of fatty acid biosynthesis
A variety of short BCCAs were evaluated for their ability to act as fatty acid primers. Along
with the various ones with a methyl branch at position 2 on the acyl chain, trimethyl acetate and
2,2-dimethylbutyric acid also rescued the growth of the BCFA- deficient mutant to significant
extents at 37ºC but not at 10ºC. Precursors having a branch at the third position such as 3-MP or
isovalerate failed to support growth of MOR401 or cld-2 [5]. This indicates that a branch at the 2position is an important structural parameter of the precursors for fulfillment of this function. Both
Kaneda [13] and Willecke and Pardee [15] found that branching at the 2-position was important
for BCCAs to act as fatty acid primers in B.subtilis. However, they did not include studies of the
efficiency of these precursors at low temperatures. Although it is possible that the poor ability of
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3-branched BCCAs to act as primers may lie in a low efficiency of forming the CoA derivatives,
we feel that it is more likely that the defect lies in the substrate preferences of FabH.
The fatty acid profile of the membrane does show incorporation of novel BCFAs when the
mutant is grown in presence of trimethyl acetate or 2,2-dimethylbutyrate. The novel fatty acids
generated from trimethyl acetate and 2,2-dimethylbutyrate totaled 41.3% and 29.5% respectively
compared to 82%, 76.8% and 93% from 2-EB, 2-MP and 2-MB respectively, all of which had a
much larger impact on the fatty acid composition of MOR401 grown in unsupplemented medium.
The major impact of trimethyl acetate and 2,2-dimethylbutyrate was to diminish the even-SCFA
content, whereas the iso-odd BCFAs actually increased. Assuming these two BCCAs permeate the
membrane efficiently we suspect the two groups at the 2-position confer a bulkier structure that
renders these compounds to be poor substrates for either the enzymes in the pathway forming their
CoA derivatives, or their utilization by FabH (or both). These BCCA precursors stimulate growth
at 37ºC, and presumably increase the fluidity of the membrane sufficiently, even though we did
not detect this in our anisotropy measurements, which may miss subtle, but important fluidity
changes.. We propose that conversion of trimethyl acetate and 2,2-dimethylbutyrate to CoA
derivatives and/or their utilization by FabH are too inefficient at 10ºC for stimulation of growth of
MOR401.
Our observations raise the question of how the preference for branched-chain precursors can
be reconciled with a sterically narrowed FabH substrate access site as identified by Gajiwala [26].
Also how does the structure of the active site account for a selective difference between 2- and 3branched precursors? The definitive answers await a L. monocytogenes FabH crystal structure
with a bound branched-chain precursor.

However, one hypothesis is that the impinging

phenylalanine may allow stabilizing Van der Waals interactions with an alkyl group on the 218

position of the CoA precursor. The increased contact likely stabilizes the acyl-CoA precursor for
efficient catalysis to occur. In the case of a branch in the 3-position, the same stabilizing contact
would leave a two-carbon overhang which would likely be a similar poor substrate for L.
monocytogenes FabH as acetyl-CoA [19].
e. Concluding remarks
Sun et al. [11, 12] reported 2-MB supplementation in the BCFA-deficient mutant plays a key
role in expression of virulence properties such as listeriolysin O and survival against CAMPs, and
peptidoglycan hydrolases and survival in an in vivo model. Since the novel fatty acids produced
from 2-MP and 2-EB also lead to similar membrane biophysical properties in the mutant as when
anteiso C15:0 and C17:0 are produced from 2-MB,, we can predict that they may have similar
effects on the physiology and pathogenicity of the pathogen. In support of this 2-MB, 2-MP and
2-EB all corrected the defective cell division of the mutant. In terms of modulating the fatty acid
composition of wild-type L. monocytogenes in order to inhibit growth in food, or in vivo,
increasing the content of SCFAs from butyrate appears to be the most effective way. The current
studies illustrate an interesting picture as to how the putative fatty acid metabolic enzymes in
Listeria adapt themselves efficiently to form novel products from synthetic precursors by nonnative promiscuity to support the membrane integrity for proper survival. Future studies will
investigate the functional properties of the membranes containing large amounts of unnatural fatty
acids.
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Table 1. Various branched-chain carboxylic acids with diverse branching pattern and chain lengths
Fatty acid precursors

Chemical structure

Trimethyl acetate (C5)

Branch

2,2-dimethyl

2-methylbutyrate (C5)

2 methyl

2,2-dimethylbutyrate

Chain length
of
hydrocarbon
backbone
3C

4C

2,2-dimethyl

4C

2-ethylbutyrate (C6)

2 ethyl

4C

2-methylpentanoate

2 methyl

5C

3 methyl

5C

4 methyl

5C

2 methyl

6C

2-ethylhexanoate (C8)

2 ethyl

6C

4-methylhexanoate

4 methyl

6C

2 methyl

7C

(C6)

(C6)
3-methylpentanoate
(C6)
4-methylpentanoate
(C6)
2-methylhexanoate
(C7)

(C7)
2-methylheptanoate
(C8)
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Table 2. The membrane fatty acid profile of L. monocytogenes parent strain 10403S and the
BCFA-deficient mutant MOR401 grown in BHI at 37ᵒC with or without BCCA precursors
% (wt/wt) of total fatty acids
Strain,
growth
conditions

Strai
Iso Iso ght
odd even even

Anteiso odd
C15:0 C17:0 SUM
47.77± 34.76
10403S 0.59 ±0.4 82.5 11.7 3.82 1.94
5.4±1.
MOR401
9
2±1.8 7.4 1.6 24.1 57.2
MOR401+ 52.3±1 40±0.
2MB
.5
7
93.1 ND 0.74 6.2

MOR401+ 0.6±0. 1.8±0.
2EB
01
3
2.3

ND 2.39 12.4

Novel fatty acids

BCFA SCFA

ND

ND

ND

98.07 1.94

ND

ND

ND

33.2

66.0

ND
ND
93.8
12ethyltetra
14decanoic ethylhexadec
acid
anoic acid
50.4±2.7 31.6±0.6
86.8

6.2

ND

ND
10methyltr 1214idecanoi methylpe methylhepta
c acid ntadecan decanoic
MOR401+ 1.4±0. 2.4±0.
1.04±0. oic acid
acid
2MP
5
7
3.8 ND 10.5 5.4
08
64.5±0.6 12.3±2.6 92.4
1214dimethyl dimethylpent
MOR401+
tridecano adecanoic
trimethyl 7.6±1. 10.2±
ic acid
acid
acetate
3
0.1 17.8 ND 28.1 11.2 ND 21.1±1.4 20.2±1.4 87.2
12,1214,14MOR401+
dimethylt dimethylhex
2,2etradecan adecanoic
dimethylb 9.5±1. 12.02
oic acid
acid
utyrate
5
±0.01 21.5 ND 35.3 10.8 ND 21.5±1.6
8±0.6
86.3

13.3

6.8

11.2

13.7

All supplements were used at 1 mM.
The percentages of respective fatty acids are means from three independent experiments with
standard deviations
ND- Not detected
The minor fatty acids (<1%) are not reported. This includes minor percentages of odd numbered
SCFAs in some cases.
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Table 3. The membrane fatty acid profile of L. monocytogenes parent strain 10403S and the
BCFA-deficient mutant MOR401 supplemented with BCCA precursors grown in BHI at 10ᵒC
% (wt/wt) of total fatty acids
Strain,
growth
condition
s

Iso Iso
Anteiso odd
odd even
C15:0 C17:0 SUM

Novel fatty acids

BCFA SCFA

69.9±1
10403S
.5 7.6±0.8 78.6 15.2 4.9

ND

ND

ND

98.8

0.6

MOR401 77.9±1 15.8±0.
+2MB
.4
5
94.7 ND 0.1

ND

ND

ND

95.3

3.6

MOR401 1.4±0.
+ 2EB
21 1.5±0.7 2.9

MOR401 1.7±0.
+2MP
18 0.6±0.8 2.3

12ethyltetrad
14ecanoic ethylhexadecan
acid
oic acid
ND 4.3
ND
65.9±5.5
14.2±2.6
87.7 10.8
1210methylpent
14methyltride adecanoic methylheptadec
canoic acid
acid
anoic acid
ND 11.8 14.4±5
65.9±0.42
0.5±0.63
94.2 4.5

All supplements were used at 1 mM.
The percentages of respective fatty acids are means from three independent experiments with
standard deviations
ND- Not detected
The minor fatty acids (<1%) are not reported.
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1
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0
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5
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0.8
0.6
0.4
0.2
0
0

5
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MOR401
2-EB

20

Butyrate
2-MP

Fig.1. Influence of the BCCA precursors on the growth of the BCFA-deficient mutant
MOR401 (a) at 37ºC and (b) at 10ºC Symbols: (♦) parent strain 10403S; all other symbols are
strain MOR401 with no supplementation (■) or supplemented with butyrate (▲) 2-MB (x) 2-EB
(Δ) 2-MP (●) 3-MP (+) Representative figures from triplicate experiment sets are shown.
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227
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125
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225
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m/z

Fig. 2. Mass spectral analysis of membrane fatty acids of the BCFA-deficient mutant strain
MOR401 when grown in presence of 2-EB
Two novel fatty acid methyl ester peaks with retention times (a) 2.75 min and (b) 3.38 min from
the GLC analysis were subjected to mass spectral analysis. The peaks yielded spectra that
correspond to (a) an ethyl branch on the 12 carbon of a 14 carbon chain, and (b) on the 14th carbon
on a 16 carbon chain.
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0.35

Anisotropy

0.3
0.25
0.2
0.15
0.1
0.05
0

strains
Fig. 3. Influence of the short chain carboxylic acid precursors on the membrane fluidity of
the BCFA-deficient mutant strain MOR401 at 37ºC
The strains were grown in medium supplemented with the indicated fatty acid precursors and
membrane anisotropy was measured by fluorescence polarization.
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a

b

c

d

Fig.4. Light microscopic analysis of the BCFA-deficient mutant MOR401 under the
influence of different fatty acid precursors
Compared to the wild type Listeria monocyogenes 10403S cells (a), the BCFA-deficient mutant
grown in unsupplemented BHI (b) is unusually long and exhibits irregular division sites (pointed
out by arrows) Precursors 2-MB (c) and 2-EB (d) restored the cell dimensions and normal cell
division. Scale bar= 4 µm
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1
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2-methylhexanoate
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10 Time (hrs)
20

10403S
2-methylhexanoate
4-methylhexanoate

MOR401

30

MOR401
2-ethylhexanoate

Fig.5. Influence of various short BCCA precursors on the growth of the BCFA-deficient
mutant strain MOR401 at 37ºC
Representative figures from triplicate experiment sets are shown. (a) ♦ parent strain 10403S;
■ MOR401 with no supplementation; ▲ MOR401 with 2,2-dimethylbutyrate (b)♦ parent strain
10403S; ■ MOR401 with no supplementation; ▲ MOR401 with trimethylacetate (c)♦ parent
strain 10403S; ■ MOR401 with no supplementation; ▲ MOR401 with 2-methylhexanoate (d)
♦ parent strain 10403S; ■ MOR401 with no supplementation; ▲ MOR401with 2methylhexanoate; x MOR401with 2-ethylhexanoate; ● MOR401with 4-methylhexanoate
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Branched
Chain amino
Branched-chain amino acid
transaminase (bcat)
Alpha-keto
acids
Branched-chain alpha keto
acid dehydrogenase (bkd)
Branched-chain acyl
phosphates

Branched-chain
acyl CoA
Phosphotransbutyrylase (ptb)

Butyrate kinase
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Elongation of primers
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Cytoplasmic Membrane

Exogenous short
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Fig.6. Endogenous pathway for membrane BCFA production and the putative pathway for
exogenous BCCA utilization in L. monocytogenes
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CHAPTER II
GROWTH-ENVIRONMENT DEPENDENT MODULATION OF STAPHYLOCOCCUS
AUREUS BRANCHED-CHAIN TO STRAIGHT-CHAIN FATTY ACID RATIO
AND INCORPORATION OF UNSATURATED FATTY ACIDS
Abstract
The fatty acid composition of membrane glycerolipids is a major determinant of
Staphylococcus aureus membrane biophysical properties that impacts key factors in cell
physiology including susceptibility to membrane active antimicrobials, pathogenesis, and response
to environmental stress. The fatty acids of S. aureus are considered to be a mixture of branchedchain fatty acids (BCFAs), which increase membrane fluidity, and straight-chain fatty acids
(SCFAs) that decrease it. The balance of BCFAs and SCFAs in USA300 strain JE2 and strain
SH1000 was affected considerably by differences in the conventional laboratory medium in which
the strains were grown with media such as Mueller-Hinton broth and Luria broth resulting in high
BCFAs and low SCFAs, whereas growth in Tryptic Soy Broth and Brain-Heart Infusion broth led
to reduction in BCFAs and an increase in SCFAs. Straight-chain unsaturated fatty acids (SCUFAs)
were not detected. However, when S. aureus was grown ex vivo in serum, the fatty acid
composition was radically different with SCUFAs, which increase membrane fluidity, making up
a substantial proportion of the total (<25%) with SCFAs (>37%) and BCFAs
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(>36%) making up the rest. Staphyloxanthin, an additional major membrane lipid component
unique to S. aureus tended to be greater in content in cells with high BCFAs or SCUFAs. Cells
with high staphyloxanthin content had a lower membrane fluidity that was attributed to increased
production of staphyloxanthin. S. aureus saves energy and carbon by utilizing host fatty acids for
part of its total fatty acids when growing in serum, which may impact biophysical properties and
pathogenesis given the role of SCUFAs in virulence. The nutritional environment in which S.
aureus is grown in vitro or in vivo in an infection is likely to be a major determinant of membrane
fatty acid composition.

Introduction
Staphylococcus aureus is a worldwide significant pathogen in the hospital and the
community. Antibiotic resistance has developed in waves

such that we now have methicillin-

resistant S. aureus (MRSA), vancomycin-resistant S. aureus (VRSA) and vancomycinintermediate S. aureus (VISA) [2,3]. Given the threat of multiply antibiotic-resistant S. aureus,
various aspects of staphylococcal biology including pathogenicity, antibiotic resistance, and
physiology are currently being investigated intensively, in part to support the search for novel antistaphylococcal agents.
The bacterial cytoplasmic membrane forms an essential barrier to the cell and is composed
of a glycerolipid bilayer with associated protein molecules, and is a critical determinant of cell
physiology. The biophysical properties of the membrane are to a large extent determined by the
fatty acyl residues of membrane phospholipids and glycolipids [4,5]. The lipid acyl chains
influence membrane viscosity/fluidity, and impact the ability of bacteria to adapt to changing
environments, the passive permeability of hydrophobic molecules, active transport, and the
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function of membrane-associated proteins [4–6]. Additionally, membrane fatty acid composition
has a major influence on bacterial pathogenesis, critical virulence factor expression [7], and
broader aspects of bacterial physiology [8].
S. aureus membrane fatty acids are generally considered to be a mixture of branchedchain fatty acids (BCFAs) and straight-chain fatty acids (SCFAs) [9–11], and for a comprehensive
review of earlier literature see [12]. In S. aureus the major BCFAs are odd-numbered iso and
anteiso fatty acids with one methyl group at the penultimate and antepenultimate positions of the
fatty acid chains, respectively (Fig. 1). BCFAs have lower melting points than equivalent SCFAs
and cause model phospholipids to have lower phase transition temperatures [13], and disrupt the
close packing of fatty acyl chains [14,15].
Fatty acids are major components of the S. aureus phospholipids, which are phosphatidyl
glycerol, cardiolipin and lysysl-phosphatidyl glycerol [16]. BCFAs are biosynthesized from the
branched-chain amino acids, isoleucine (anteiso odd-numbered fatty acids), leucine (iso oddnumbered fatty acids), and valine (iso even-numbered fatty acids) via branched-chain
aminotransferase and branched-chain α- keto acid dehydrogenase [13]. The branched-chain acyl
CoA precursors thus formed are used for the biosynthesis of fatty acids by the dissociated
bacterial fatty acid synthesis system (FASII) [5,17]. Phosphatidic acid is a key intermediate in
the biosynthesis of the S. aureus phospholipids [5]. Our current knowledge of the pathway of
phospholipid biosynthesis and the incorporation of exogenous and endogenous fatty acids is
summarized in Fig. 2 [18]. Phosphatidic acid, the universal precursor of phospholipids, is
synthesized by the stepwise acylation of sn-glycerol-3-phosphate first by PlsY that transfers a
fatty acid to the 1-position from acyl phosphate. The 2-position is then acylated by PlsC utilizing
acyl-ACP. Acyl-ACP is produced by the FASII pathway and PlsX catalyzes the interconversion
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of acyl-ACP and acyl phosphate. When S. aureus is grown in medium that results in a high
proportion of BCFAs the major phospholipid, phosphatidyl glycerol, has, almost exclusively,
anteiso C17:0 at position 1 and anteiso C15:0 at position 2 [17].
The membrane lipid composition of S. aureus is further complicated by the presence of
staphyloxanthin, a triterpenoid carotenoid with a C30 chain with the chemical name of α-Dglucopyranosyl-1-O-(4,4’-diaponeurosporen-4-oate)-6-O (12-methyltetradecanoate) [19](Fig.
1). Staphyloxanthin, as a polar carotenoid, is expected to have a significant influence on
membrane properties with the expectation that it rigidifies the membrane [20], and Bramkamp
and Lopez [21] have suggested that staphyloxanthin is a critical component of lipid rafts in S.
aureus incorporating the organizing protein flotillin. Staphyloxanthin has drawn considerable
attention in recent years as a possible virulence factor by detoxifying reactive oxygen species
produced by phagocytic cells [22,23] , and as a potential target for antistaphylococcal
chemotherapy [24].
In our laboratory, we are interested in the mechanisms of action of and resistance to novel
and existing anti-staphylococcal antimicrobials [25–27]. Because much antibiotic work employs
Mueller-Hinton (MH) medium, [28] we had occasion to determine the fatty acid composition of a
S. aureus strain grown in this medium. The analysis was carried out using the MIDI microbial
identification system (Sherlock 4.5 microbial identification system; Microbial ID, Newark, DE,
USA), [29]. We were taken aback when the fatty acid profile came back showing a very high
percentage (84.1%) of BCFAs, and the organism was not even identified by MIDI as a S. aureus
strain. In a previous study where we grew S. aureus in BHI broth we found that 63.5% of the fatty
acids were BCFAs, and 32.4% were SCFAs [10]. This is a much more typically observed balance
between BCFAs and SCFAs in previous studies of the fatty acid composition of S. aureus [9–12].
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A range of different media are used for cultivating S. aureus in studies from different
laboratories [30]. These are mostly complex media such as Tryptic Soy Broth (TSB), BHI broth,
MH broth, Luria-Bertani (LB) broth, and, much more rarely, defined media [11]. Ray et al. [30]
and Oogai et al [31] have pointed out that different media have major, but largely unstudied and
ignored, effects on the expression of selected target virulence and regulatory genes. Although
seemingly prosaic at first glance, issues of choice of strain and medium are nevertheless critical
considerations in staphylococcal research [32]. These authors [32], in their recent protocol
publication on the growth and laboratory maintenance of S. aureus, have suggested that TSB and
BHI media are the media of choice for staphylococcal research. In light of recent literature in
various microorganisms, it is becoming evident that environment has a tremendous effect on the
physiology of different pathogens; hence cells from in vivo growth are significantly different from
in vitro cultured ones. Such distinctions are likely important for studying antimicrobial
susceptibilities, drug resistances and pathogenesis.
We decided to carry out a systematic study of the impact of growth medium on the fatty
acid and carotenoid composition of S. aureus given the large potential impact of these parameters
on membrane biophysical properties and its further ramifications. The BCFA: SCFA ratio was
significantly impacted by the laboratory medium used, with media such as MH broth encouraging
high proportions of BCFAs. However, strikingly, when cells were grown in serum, an ex vivo
environment, the fatty acid composition changed radically, with straight-chain unsaturated fatty
acids (SCUFAs) (Fig. 1), which were not detected in cells grown in laboratory media, making up
a major proportion of the total fatty acids. This extreme plasticity of S. aureus membrane lipid
composition is undoubtedly important in determining membrane physical structure and thereby
the functional properties of the membrane. The alterations in the fatty acid composition as a result
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of interactions of the pathogen with the host environment may be a crucial factor in determining
its fate in the host. Typically used laboratory media do not result in a S. aureus membrane fatty
acid composition that closely resembles the likely one of the organism growing in vivo in a host.

Materials and Methods
Bacterial Strains and Growth Conditions
The primary S. aureus strains studied were strain JE2 derived from strain LAC USA300 [33]
and strain SH1000. USA300 strain JE2 is a prominent community-acquired MRSA lineage, which
is a leading cause of aggressive cutaneous and systemic infections in the USA [1,34,35]. Strain
JE2 has a well-constructed diverse transposon mutant library [33]. S. aureus strain SH1000, is an
8325-line strain that has been used extensively for many years in genetic and pathogenesis studies
[36]. The laboratory media used were MH broth, TSB, BHI broth and LB from Difco. For growth
and fatty acid composition studies cultures of S. aureus strains were grown at 37° C in 250 ml
Erlenmeyer flasks containing each of the different laboratory media with a flask–to-medium
volume ratio of 5:1. Growth was monitored by measuring the OD600 at intervals using a Beckman
DU-65 spectrophotometer.
Growth of S. aureus in Serum
Sterile fetal bovine serum of research grade was purchased from Atlanta Biologics, USA.
The aliquoted serum was incubated in a water bath at 56° C for 30 min to heat inactivate the
complement system. S. aureus cells were grown for 24 hours in 50 ml of serum in a 250 ml flask
at 37°C with shaking at 200 rpm.
Analysis of the Membrane Fatty Acid Composition of S. aureus Grown in Different Media
The cells grown in the different conventional laboratory media were harvested in midexponential phase (OD600 0.6), and after 24 hrs of growth in serum, by centrifugation at 3000 x g
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at 4° C for 15 minutes and the pellets were washed three times in cold distilled water. The samples
were then sent for fatty acid methyl ester (FAME) analysis whereby the fatty acids in the bacterial
cells (30-40 mg wet weight) were saponified, methylated, and extracted. The resulting methyl ester
mixtures were then separated using an Agilent 5890 dual-tower gas chromatograph and the fatty
acyl chains were analyzed and identified by the MIDI microbial identification system (Sherlock
4.5 microbial identification system) at Microbial ID, Inc. (Newark, DE) [29]. The percentages of
the different fatty acids reported in the tables and figures are the means of the values from three
separate batches of cells under each condition. Some minor fatty acids such as odd-numbered
SCFAs were not reported.
Extraction and Estimation of Carotenoids
For quantification of the carotenoid pigment in the S. aureus cells grown in different
media, the warm methanol extraction protocol was followed as described by Davis et al.
[37]. Cultures of S. aureus were harvested at mid-exponential phase and were washed with
cold water. The pellets were then extracted with warm (55ºC) methanol for 5 min. The OD465
of the supernatant after centrifugation was measured using a Beckman DU 70
spectrophotometer. Determinations were carried out in triplicate. Significant differences
between carotenoid content of S. aureus grown in different media were determined by
analysis of variance (ANOVA) using SAS 9.4 (SAS Institute, NC) with post hoc Tukey’s
test.

Measurement of the Fluidity of the S. aureus Membrane
The fluidities of the cell membrane of the S. aureus strains grown in different media were
determined by anisotropic measurements using the fluorophore diphenylhexatriene (DPH)
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following the protocol described previously [38]. Mid exponential phase cells grown in
respective media and serum were harvested and washed with cold sterile PBS (pH 7.5). The
pellets were then resuspended in PBS containing 2 µM DPH (Sigma, MO) to an OD600 of about
0.3 and incubated at room temperature in the dark for 30 min. Fluorescence polarization emitted
by the fluorophore was measured using a PTI Model QM-4 Scanning Spectrofluorometer at an
excitation wavelength of 360 nm and emission wavelength of 426 nm. The experiments were
performed with three separate fresh batches of cells. Significant differences between mean
polarization values of S. aureus grown in different media were determined by analysis of
variance (ANOVA) using SAS 9.4 (SAS Institute, NC) with post hoc Tukey’s test.

Results
The two main strains studied were USA300 strain JE2 and strain SH1000. The
genome sequences of both strains are known. The USA300 JE2 background represents the most
prominent community-associated methicillin resistance lineage in the US, and is the strain in
which the Nebraska Transposon Mutant Library is constructed [33]. Strain SH1000 is an 8325line strain in which the defect in SigB has been corrected [39], and for many years 8325-line
strains have been used as model strains in genetic studies of staphylococcal pathogenesis [36].
These strains were chosen for their significance as pathogens, well-developed knowledge of
their genetics, physiology and virulence, and familiarity to the staphylococcal research
community.
MH broth and LB Increase the Content of BCFAs and TSB and BHI Broth Increase the
Content of SCFAs
The fatty acid compositions of strain JE2 grown in different laboratory media are shown
in Fig. 3 and in more detail in S1 Table. Growth in MH broth and LB resulted in a high content
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of BCFAs, 80.9% and 77.2% respectively, whereas SCFAs were 19.1% and 22.8% respectively.
However, in TSB and BHI broth the BCFAs contents were lower at 51.7% and 51.5%
respectively, and SCFAs were increased to 48.3 and 48.5% respectively. In MH broth anteiso
odd-numbered fatty acids were the major fatty acids in the profile (59.8%), followed by evennumbered SCFAs (16.6%), iso odd-numbered fatty acids (15.8%), with iso even-numbered fatty
acids making up only a minor portion (4.7%). Anteiso C15:0 was the predominant fatty acid in
the membrane lipids (39%). This particular fatty acid has a significant impact on fluidizing
membranes [40,41]. The anteiso fatty acids were significantly reduced in TSB-grown cells
(29.3%). The major SCFAs in TSB-grown cells were C18:0 and C20:0 at 19.1% and 18.6%
respectively. Overall, the fatty acid compositions were in line with many previous studies of S.
aureus fatty acid composition [9–12], but we are unaware of previous studies that have identified
this impact of medium on the proportions of BCFAs and SCFAs in the membrane.
The results of a similar series of experiments with strain SH1000 are shown in Fig. 4 and
S2 Table. In strain SH1000 the BCFAs were higher than JE2 in all media- BHI 66.6%, TSB
68.5%, with particularly high contents in MH broth, 90.2%, and LB, 89%. The proportion of
SCFAs was correspondingly smaller in all cases compared to strain JE2. Anteiso fatty acids
were the major class of fatty acids in all media, amongst which anteiso C15:0 was present in
the highest amount in all cases. However, the same phenomenon was noted where MH broth
and LB encouraged a high proportion of BCFAs, low SCFAs, and TSB and BHI had the
opposite effects on fatty acid composition. Two additional media were studied with this strain.
Both Tryptone Broth [42] and defined medium [43] resulted in high BCFAs (80.4% and 85%
respectively), and low SCFAs (19.7% and 15% respectively).
The Fatty Acid Composition of S. aureus Grown ex vivo in Serum is Radically Different to
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Those of the Organism Grown in Laboratory Media
It was of interest to try and get an idea of the fatty acid composition of S. aureus grown
in vivo. Strain JE2 and SH1000 were grown ex vivo in serum, which resulted in major changes
in the fatty acid profile (Figs. 3 & 4 and S1 and S2 Tables). Total BCFAs were reduced to 37.5%
in JE2 and 36.3% in SH1000; SCFAs were at 37.8% in JE2 and 32.1% in SH1000, but 25% of
the fatty acid profile in the case of JE2 and 30.6% in SH1000 was accounted for by SCUFAs.
Strikingly, this type of fatty acid was not present in the profile of the organism when grown in
laboratory media. Interestingly, BCFAs and SCUFAs have similar effects in increasing fluidity
of the membrane [4].
Carotenoid Content of Cells Grown in Different Media
Staphyloxanthin is another significant membrane component that might impact the
biophysical properties of the membrane. Accordingly, the carotenoid contents of cells grown in
different media were determined and the results are shown in Fig. 5. Strain SH1000 cells grown
in MH broth had a much higher carotenoid content than cells grown in the other media. The
pellets of cells grown in this particular media were noticeably yellow. It is possible that the
carotenoid content rises to counterbalance the potentially high fluidity of MH broth-grown cells
with their high content of BCFAs, specifically mainly anteiso fatty acids. MH broth (high
BCFAs) and serum (high SCUFAs) - grown cells had higher carotenoid contents than TSB or
BHI broth –grown cells as revealed by statistical analysis of the data (Fig. 5), which
demonstrated that the carotenoid content of cells grown in MH broth was distinctly different
from cells grown in other media. In strain JE2 MH broth- and serum-grown cells also had higher
carotenoid contents than did cells grown in BHI broth, TSB or LB. In general, this strain was
less pigmented than strain SH1000. Statistical analysis of S. aureus strain JE2 carotenoid content
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showed that cells grown in MH broth and serum were placed in the same group, and the cells
grown in BHI broth, LB and TSB were in a different group.
Membrane Fluidity of S. aureus Cells Grown in Different Media
The membrane fluidity of cells of strain SH1000 grown in BHI broth, LB and TSB were
very similar (0.185-0.19) as shown in Fig. 6. The membranes of MH-broth and serum-grown
cells, 0.25 and 0.248 were significantly less fluid than cells grown in the other media. Possibly
the higher carotenoid contents of cells grown in MH broth and serum rigidify the membrane.
Strain JE2 also showed a similar pattern of membrane fluidity in the different growth media
(Fig. 6). The membrane fluidity of both strains was highest in cells grown in LB, consistent with
the high content of BCFAs. Furthermore, in this medium there was no accompanying increase
in staphyloxanthin content with its possible membrane rigidifying effect in contrast to what was
observed in MH broth or serum-grown cells. Statistical analysis showed that the fluorescence
polarization values of both S. aureus strain JE2 and SH1000 grown in MH broth and serum were
significantly different from the cells grown in BHI broth, TSB and LB as indicated in Fig. 5.

Discussion
From numerous studies over the past several decades of S. aureus grown in vitro in
various laboratory media it is considered that the membrane fatty acid composition of the
organism is a mixture of BCFAs and SCFAs [9–12], and BCFAs have generally been found to
be predominant. Through study of a range of different conventional growth media, we found
that certain media encouraged a higher proportion of BCFAs than others, whereas in some media
the proportion of SCFAs was increased. This may have significant physiological ramifications
given the opposing effects of BCFAs and SCFAs on membrane fluidity with BCFAs fluidizing
and SCFAs rigidifying the membrane [4]. However, there was a radical change in the entire fatty
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acid composition when the organism was grown ex vivo in serum with SCUFAs appearing in
the profile in significant amounts accompanied by a decrease in BCFA content.
What Determines the Balance Between BCFAs and SCFAs in Cells Grown in Laboratory
Media?
MH medium leads to a high proportion of BCFAs in the staphylococcal cells, whereas
growth in TSB leads to an increase in the proportion of SCFAs. MH broth (Difco) is composed of
beef extract powder (2 g/l), acid digest of caseine (17.5 g/l), and soluble starch (1.5 g/l). Thus, by
far the major medium component is acid digest of caseine, and this is expected to be high in free
amino acids. TSB (Difco) is composed of pancreatic digest of caseine (17 g/l), enzymatic digest
of soybean meal (3 g/l), dextrose (2.5 g/l), sodium chloride (5 g/l) and dipotassium phosphate (2.5
g/l). The major components then of TSB are a mixture of peptides formed by enzymatic digestion
of caseine and soybean meal. Payne and Gilvarg [44] fractionated Bacto Neopeptone using gel
filtration. They found that peptides with a molecular weight below 650 represented about 25% of
the mixture, and free amino acids were about 1% of the entire preparation. We believe that the free
amino acids from the acid digest of caseine can have a dominant effect on the fatty acid
composition. Inclusion of isoleucine, leucine, or valine in the growth medium of Listeria
monocytogenes results in large increases in fatty acids derived from the particular amino acid in
question [29,45]. The BCFA content of S. aureus is lower in S. aureus grown in TSB, where pool
amino acids are likely to be mainly derived from transported peptides [46], than when grown in
defined medium, which probably gives rise to higher pool levels of amino acids [47] and this
work. Mutants of S. aureus in the transporters of leucine and valine lacked odd- and evennumbered fatty acids derived from these amino acids when grown in defined medium [47].
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Growth in media such as TSB and BHI broth lead to higher proportions of SCFAs than
media such as MH broth, although SCUFAs were not detected. The origin of SCFAs is not clear
as to whether they originate from the medium or are biosynthesized. Typically, in bacteria SCFAs
are biosynthesized from acetyl CoA via the activities of FabH and the FASII system. However,
acetyl CoA was a poor substrate for S. aureus FabH [48], whereas the enzyme had high activity
for butyryl CoA, raising the possibility that butyrate is the primer for biosynthesis of SCFAs in S.
aureus. It is also possible that SCFAs that may be present in TSB and BHI may be utilized directly
for fatty acid elongation to the SCFAs in the membrane typical of growth in these media.
The Underappreciated Ability of S. aureus to Incorporate Host Fatty Acids from Serum
A striking finding in our paper is that S. aureus has the capacity to incorporate large
proportions of SCFAs and SCUFAs when grown ex vivo in serum. Earlier reports of fatty acid
composition have not reported significant amounts of SCUFAs in S. aureus [9–12]. Indeed, it
appears that S. aureus lacks the genes necessary to biosynthesize unsaturated fatty acids [18]. An
early report by Altenbern [49] showed that inhibition of growth by the fatty acid biosynthesis
inhibitor cerulenin could be relieved by SCFAs or SCUFAs, implying S. aureus had the ability to
incorporate preformed fatty acids. Fatty acid compositional studies of the cells were not reported
though. Serum is lipid rich [50–52] and a comprehensive analysis of the human serum metabolome
including lipids has recently been published [53]. BCFAs are present, if at all, in only very small
amounts in serum. Bacterial pathogens typically have the ability to incorporate host-derived fatty
acids thereby saving carbon and energy since fatty acids account for 95% of the energy
requirement of phospholipid biosynthesis [54]. Exogenous fatty acids readily penetrate the
membrane and are activated by a fatty acid kinase to produce acyl phosphate that can be utilized
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by PlsY for incorporation into the 1 position of the glycerol moiety of phospholipids, or they can
be converted to acyl-ACP for incorporation into the 2 position by PlsC (Fig. 2) [18].
The FASII pathway has been considered to be a promising pathway for inhibition with
antimicrobial drugs. The viability of FASII as a target for drug development was challenged by
Brinster et al. [55] especially for bacteria such as streptococci where all the lipid fatty acids could
be replaced by SCFAs and SCUFAs from serum. However, Parsons et al. [17] showed that
exogenous fatty acids could only replace about 50% of the phospholipid fatty acids in S. aureus
and concluded that FASII remained a viable drug target in this organism.
Besides occurring in membrane phospholipids, fatty acids are present in
staphyloxanthin, glycolipids and lipoteichoic acid and in lipoproteins at their N terminus in the
form of an N-acyl-S-diacyl-glycerol cysteine residue and an additional acyl group amide linked to
the cysteine amino group [56]. It is estimated that there are 50-70 lipoproteins in S. aureus, and
many of them are involved in nutrient acquisition. The distribution of growth environment-derived
SCFAs and SCUFAs in these lipid molecules has not yet been examined.
Changes in Staphyloxanthin in Cells Grown Under Different Conditions with Different
Membrane Fatty Acid Compositions
The carotenoid staphyloxanthin is a unique S. aureus membrane component that affects
membrane permeability, defense against reactive oxygen species, and is a potential drug target. It
appeared that cells grown in media encouraging a high proportion of BCFAs or in serum resulting
in high SCUFAs, both of which would be expected to increase membrane fluidity, tended to have
higher staphyloxanthin contents. Cells grown in MH broth or serum had cellular membranes that
were less fluid that may be attributable to the higher content of staphyloxanthin. However, this
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relationship is likely to be complex in that LB-grown cells that had high BCFAs did not have high
carotenoid levels, and the phenomenon is deserving of more detailed investigation. Interestingly,
in the biosynthesis of staphyloxanthin, the end step involves an esterification of the glucose moiety
with the carboxyl group of anteiso C15:0 by the activity of the enzyme acyltransferase CrtO [19].
It is not known whether anteiso C15:0 can be replaced by SCUFAs.
Plasticity of S. aureus Membrane Lipid Composition and its Possible Ramifications in
Membrane Biophysics and Virulence
Given the crucial role of the biophysics of the membrane in all aspects of cell
physiology, such radical changes in the membrane lipid profile can have significant but as yet
undocumented impacts on critical functional properties of cells such as virulence factor
production, susceptibilities to antimicrobials and tolerance of host defenses. It is important to
assess the biophysical and functional properties of the membranes of the cells with such radically
different fatty acid compositions.
The susceptibilities of the strains to three antibiotics designated as hydrophobic,
oxacillin, vancomycin and rifampicin and three designated as hydrophilic, chloramphenicol,
penicillin G, and tetracycline [57], were determined on TSB, BHI, MH, LB and serum agar plates
by disk diffusion. There was no striking difference in antibiotic susceptibilities between the
different artificial media. Zones of inhibition were markedly lower in both strains on serum agar
for rifampicin, chloramphenicol, and tetracycline. However, membrane permeability studies
clearly need to be done in a more simplified system such as lipid vesicles of defined fatty acid
composition [58] to simplify the interpretation of any differences observed. Cells grown in serum
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had higher hemolytic activity, and MH broth and serum- grown cells had lower autolytic activities
than cells grown in the other media (unpublished observations).
Although BCFAs and SCUFAs both increase membrane fluidity, they do not yield
cells with identical morphologies [15], or fitness for tolerating cold stress [59]. Also a S. aureus
fatty acid auxotroph created by inactivation of acetyl coenzyme A carboxylase (ΔaccD) was not
able to proliferate in mice, where it would have access to SCFAs and SCUFAs [60]. Due to the
ability of a pathogen to adapt and undergo dramatic alterations when subjected to a host
environment, there is a growing appreciation in the research community for the fact that the
properties of the organism grown in vivo are probably very different from when it is grown in vitro.
This distinction may have a huge impact on critical cellular attributes controlling pathogenesis and
resistance to antibiotics. Expression of virulence factors is significantly different in serum-grown
organisms [31], and there are global changes in gene expression when S. aureus is grown in blood
[61]. S. aureus grown in serum or blood will have different membrane lipid compositions than
cells grown in laboratory media and this may have a significant impact on the expression of
virulence factors and pathogenesis of the organism.
The relationship between S. aureus and long-chain SCUFAs and SCFAs is a complex
one. On one hand these fatty acids in the skin and other tissues form part of the innate defense
system of the host due to their antimicrobial activities [62–64]. Very closely related structures can
either be inhibitory to growth at low concentrations, or can have little effect on growth at relatively
high concentrations [42,65–67]. For example, C16:1Δ6 and C16:1Δ9 are highly inhibitory whereas
C18:1Δ9 and C18:0 are not inhibitory and are actually incorporated into the phospholipids by this
pathogen [42].
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The enzyme fatty acid kinase (Fak) responsible for incorporation of extracellular fatty
acids into S. aureus phospholipids [18], is also a critical regulator of virulence factor expression
[68], and biofilm formation [69]. Fak phosphorylates extracellular fatty acids for incorporation
into S. aureus membrane phospholipids [18] (Fig. 2). FakA is a protein with an ATP-binding
domain that interacts with FakB1 and FakB2 proteins that bind SCFAs and SCUFAs preferentially
respectively. Fak activity producing acyl phosphates was proposed to be involved in the control of
virulence gene expression. Interestingly FakB2 shows a high degree of specificity for C18:1Δ9, a
fatty acid not produced by S. aureus, that may act as a sensor for the host environment through its
abundance in the host [18], which is subsequently incorporated into the membrane lipids.
Additionally, fatty acids are important components of lipoproteins that contribute
important microbe-associated molecular patterns that bind to Toll-like receptors and activate
innate host defense mechanisms. Recently, Nguyen et al. [70] have shown that when S. aureus is
fed SCUFAs they are incorporated into lipoproteins and the cells have an increased toll-like
receptor 2- dependent immune stimulating activity, which enhances recognition by the immune
defense system.

Concluding Remarks
We have demonstrated a hitherto poorly recognized growth environment-dependent
plasticity of S. aureus membrane lipid composition. The balance of BCFAs and SCFAs was
affected significantly by the variations in laboratory medium in which the organism grew.
SCUFAs became a major membrane fatty acid component when the organism was grown in serum.
These findings speak to the properties of pathogens grown in vitro versus in vivo. In 1960 Garber
[71] considered the host as the growth medium and the importance of the properties of the pathogen
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at the site of infection. There has been a renewed appreciation of this in recent years [72]. Massey
et al. [73] showed that S. aureus grown in peritoneal dialysate acquired a protein coat. Krismer et
al. [74] devised a synthetic nasal secretion medium for growth of S. aureus. However, Chaves
Moreno et al. [75] determined the in vivo metatranscriptome of S. aureus by RNAseq analysis of
RNA isolated from the anterior nares of documented S. aureus carriers. In vitro transcriptomes did
not mimic in vivo transcriptomes. Citterio et al. [76] reported that the activities of antimicrobial
peptides and antibiotics were enhanced against various pathogenic bacteria by supplementation of
the media with blood plasma to mimic in vivo conditions.
S. aureus may be the most versatile of all pathogens causing diseases ranging from
superficial skin infections to deep seated disseminated diseases of various organs and tissues. The
organism forms biofilms on tissues, intravenous catheters and prosthetic devices. S. aureus can
thrive in multiple heterogenous environments. We propose that the nutritional environment is the
main determinant of membrane fatty acid composition. If SCUFAs are present in the environment
these will be preferentially incorporated into the lipids to a tolerated extent, although there appears
to be a requirement for a significant proportion of biosynthesized anteiso odd-numbered fatty
acids. It is sobering to realize that the vast majority of studies of staphylococcal biology utilizing
organisms grown in artificial media have been carried out with cells lacking SCUFAs in their
membrane.
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Fig 1. Structures of major fatty acids and staphyloxanthin of the S. aureus cell membrane.
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Fig 2. Pathway of phospholipid biosynthesis and the incorporation of exogenous and
endogenous fatty acids in S. aureus.
Phosphatidic acid (PtdOH), the universal precursor of phospholipids, is synthesized by
the stepwise acylation of sn-glycerol-3-phosphate first by PlsY that transfers a fatty acid to the 1position from acyl phosphate. The 2-position is then acylated by PlsC utilizing acyl-ACP. AcylACP is produced by the FASII pathway and PlsX catalyses the interconversion of acyl-ACP and
acyl phosphate. Exogenous fatty acids readily penetrate the membrane and are activated by a fatty
acid kinase (FakB1 for SCFAs and FakB2 for SCUFAs) to produce acyl phosphate that can be
utilized by PlsY, or that can be converted to acyl-ACP for incorporation into the 2-position by
PlsC. Exogenous fatty acids can also be elongated by the FASII pathway. Figure modified from
Parsons et al. [18].
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Fig. 3. Membrane fatty acid composition of S. aureus strain JE2 cells grown in different
media.

Percent total fatty acids

Membrane fatty acid composition of log phase S. aureus strain JE2 cells grown in BHI,
TSB, MHB, LB and fetal bovine serum were summarized into the various common classes of fatty
acids. Figure shows representative data from at least three independent experiments.
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%

Unsaturated fatty acids
SCFAs
Iso even
Iso odd
Anteiso odd

BHI

TSB

MHB

LB

Serum

Fig. 4. Membrane fatty acid composition of S. aureus strain SH1000 cells grown in different
media.
Membrane fatty acid composition of log phase S. aureus strain SH1000 cells grown in BHI,
TSB, MH broth, LB and fetal bovine serum were summarized into the various common classes
of fatty acids. Figure shows representative data from at least three independent experiments.
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Supporting information
S1 Table. The membrane fatty acid profile of S. aureus strain JE2 grown in various
conventional media and in serum
% (wt/wt) of total fatty acids
Membrane fatty acids
C15:0
C17:0
Anteiso odd
C19:0
C15:0
C17:0
Iso odd
C19:0
C14:0
C16:0
Iso even
C18:0
C14:0
C16:0
Straight even
C18:0
C20:0
C16:1Δ9
C18:1Δ9
C18:1Δ7
Unsaturated fatty acids
C20:1Δ9
C20:4Δ6,9,12,15
BCFAs
SCFAs
SCUFAs
ND- Not detected
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BHI
28.5
2.6
ND
12.2
1.8
ND
2.9
1.4
ND
3.3
7.9
21.5
13.4
ND
ND
ND
ND
ND
49.4
46.1
ND

TSB
26.9
2.4
ND
12.8
2
ND
3.7
1.8
ND
2.3
6.4
19.1
18.6
ND
ND
ND
ND
ND
49.6
46.4
ND

MHB
39
15
5.8
7.7
4.9
3.2
1
2.1
1.6
1.1
1.8
6.5
7.2
ND
ND
ND
ND
ND
80.3
16.6
ND

LB
36.5
11
2.4
13.3
6.6
2.6
1.4
2.2
1
0
3
10
6.9
ND
ND
ND
ND
ND
77
19.9
ND

Serum
21
4
ND
7.1
2
0
1.7
1.7
ND
1.7
16.4
13.3
4.8
1.7
16
4.2
2.1
1
37.5
37.8
25

S2 Table. The membrane fatty acid composition of S. aureus strain SH1000 grown in various
conventional media and in serum
% (wt/wt) of total fatty acid
Membrane fatty acids
Anteiso odd

Iso odd

Iso even

Straight even

Unsaturated fatty acids

C15:0
C17:0
C19:0
C15:0
C17:0
C19:0
C14:0
C16:0
C19:0
C14:0
C16:0
C18:0
C20:0
C16:1Δ9
C18:1Δ9
C18:1Δ7
C20:1Δ9
C20:4Δ6,9,12,15
BCFAs
SCFAs
SCUFAs

ND- Not detected
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BHI

TSB

MHB

LB

Serum

33.6
6.4
1
15.7
4.3
ND
2.6
3.1
ND
2.7
8.1
15.2
6.4
ND
ND
ND
ND
ND
66.7
32.4
ND

31.6
6
ND
18.7
5.2
1.2
2.2
2.7
ND
2
7.8
15.4
6.3
ND
ND
ND
ND
ND
67.6
31.5
ND

43.7
20.7
5.7
6.8
5.1
2.3
1.2
3.1
1.6
ND
1.4
4.2
2.3
ND
ND
ND
ND
ND
90.2
7.9
ND

42
16.8
3.1
12.2
7.2
2.3
1.3
2.9
1.2
ND
2.4
6
2.6
ND
ND
ND
ND
ND
89
11
ND

18.2
3
ND
6
1.8
ND
2.4
1.6
ND
1.1
13.2
12.1
4.4
1.5
15.4
6.4
5
2.3
33
32.1
30.6

CHAPTER III
SUMMARY
The significance of a membrane homeostasis, regulated by the composition of the
lipid bilayer for survival and growth of a cell is huge. The phospholipid acyl chains influence
membrane viscosity/fluidity, and impact the ability of bacteria to adapt to changing environments,
the passive permeability of hydrophobic molecules, active transport, and the function of
membrane-associated proteins. Additionally, membrane fatty acid composition has a major
influence on bacterial pathogenesis, and broader aspects of bacterial physiology. Hence in recent
times there has been increased research to better understand the lipid biosynthetic pathways and
their regulations in bacteria pathogens to support efforts in translational medicine attempting to
target these critical processes with novel antimicrobials.
This current study highlights the dynamics of membrane lipid composition in Gram
positive bacterial pathogens and the underlying regulation and molecular networks. It also draws
attention to the fact that changes in the external environment have significant consequences on
membrane fatty acid profile and biophysical properties. In L. monocytogenes this may involve a
native metabolic pathway to form novel fatty acyl chains in the phospholipid bilayer from
synthetic precursors by non-native promiscuity to support the membrane integrity for proper
survival; thereby establishing an alternative pathway for lipid utilization. The membrane fluidity
of this pathogen is one of the critical parameters that govern its unique survival at very low
temperatures making it a leading cause of food borne infections recently. The ability to use
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synthetic molecules, which are common food additives, to produce novel fatty acids having
surprisingly correct biophysical properties to help restoring desired membrane homeostasis in
this pathogen is a remarkable find. It helps us realize the efficiency of the bacterial cell to
modulate existing pathways for proper maintenance of critical membrane parameters. Future
studies on the functional properties of such unique lipid bilayers may prove beneficial to
understand the pathogen physiology better and also provide advantage in developing novel and
efficient means of control.
In S. aureus the membrane composition was proved to be highly plastic depending
on the medium of growth; a finding that makes us question- What is the fatty acid composition
that gives S. aureus the best fitness? The proportions and components of the fatty acids change
drastically from in vitro to in vivo models, where host derived fatty acids seem to play a major
role in modulating lipid profile. In S. aureus increased membrane fluidity has been associated
with decreased susceptibility to membrane-active peptides and organic solvents. Given that MH
medium is the standard medium for antimicrobial MIC determinations it is possible that certain
compounds have higher MICs in this medium, and strains may be erroneously designated as
resistant or decreased susceptibility. Moreover, the incorporation of SCUFAs in the membrane
when grown in serum may have drastic yet unknown consequences on such susceptibilities. This
may be particularly significant in VISA and daptomycin-decreased susceptibility strains, which
typically only show small increases in MICs compared to susceptible strains. Hence it only
seems fair due to the broad lipid plasticity of this pathogen, to suggest a medium of growth
which more closely mirrors the host environment to better understand the host pathogen
interactions and its significance in the physiology of this pathogen.
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